To assess the significance of lnc-GAN1 expression in the survival of NSCLC patients, we first divided 194 patients into low- and high-lnc-GAN1 groups based on the median lnc-GAN1 level. The gene discussed is GAN; the disease is non-small cell lung carcinoma.